The Life Spectrum of Asthma Online: Asthma and COPD Overlap Syndrome (ACOS)

This module will center on further progression of asthma to where a person has clinical features of both asthma and COPD, known as Asthma and COPD Overlap Syndrome (ACOS). The talks in this module will compare and contrast the biological and environmental characteristics of asthma and COPD, as well as define appropriate treatment strategies of ACOS.

There are four talks in this module. You can view or download the videos or audio along with the presentation handouts from the following pages. 

Talk 1: Moving from the Oslerian Paradigm to the Post-genomic Era: Are Asthma and COPD Outdated Terms?
            Nicola Hanania, MD MS 

Talk 2: Pathophysiologic Mechanisms of Asthma and COPD           
            Arthur F. Gelb, MD

Talk 3: Influence of Environmental Factors on Asthma and COPD
            David B. Peden, MD MS FAAAAI 

Talk 4: Precision Therapy for ACOS
            Joe W. Ramsdell, MD

Click here to view faculty responses to audience questions asked during the talks.

The Life Spectrum of Asthma: Online is funded through an educational grant from GlaxoSmithKline.

Target Audience

  • Allergist/Immunologists
  • Fellows-in-Training
  • Allied Health providers 

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Compare and contrast the biological and environmental characteristics of asthma and COPD
  • Define appropriate treatment strategies of ACOS
Summary
Available credit: 
  • 2.00 Attendance
    Attendance credit.
  • 2.00 CME
    CME credit.
Course opens: 
10/03/2016
Course expires: 
10/02/2018
Member cost:
$60.00
Cost:
$75.00
Part of: 
The Life Spectrum of Asthma: Online
Rating: 
0

Faculty members and disclosures will be listed with each talk.

Moderator
James P. Kiley, PhD
National Institutes of Health/NHLBI
Relevant relationships: None

Planning Committee Disclosures
Thomas B. Casale, MD FAAAAI
University of South Florida
Relevant relationships: Sanofi-Regeneron, Teva, Novartis, Genentech, Boehringer Ingelheim, AstraZeneca (advisory board); Allerquest, Circassia, Capnia (consultant); Parexel (honorarium)

Robert F. Lemanske, Jr., MD FAAAAI
University of Wisconsin 
​Relevant relationships: Pharmaxis (research funding) 

CME Committee Reviewers
Kim E. Mudd, RN MSN CCRP
Johns Hopkins University, Baltimore, MD
​Relevant relationships: None

Kevin W. Parks, MD FAAAAI
AAC/CRI of Southern Oregon, Medford, OR 
​Relevant relationships: None

Available Credit

  • 2.00 Attendance
    Attendance credit.
  • 2.00 CME
    CME credit.

Price

Member cost:
$60.00
Cost:
$75.00
Please login or register to take this course.

Required Hardware/software

One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari.

Internet Explorer is not supported.